Rady Children's Hospital and Department of Pediatrics, University of California San Diego, La Jolla, CA, USA.
ResMed Science Center, Sydney, NSW, Australia.
Lancet Digit Health. 2020 Feb;2(2):e94-e101. doi: 10.1016/S2589-7500(19)30214-6. Epub 2019 Dec 23.
Positive airway pressure (PAP) has become a prominent treatment for children with sleep-disordered breathing. However, there are no large-scale studies to clarify whether PAP is well tolerated in children, and which factors are associated with better adherence to PAP therapy. In this study, we aimed to clarify adherence patterns of PAP therapy in a large paediatric population.
We did a cross-sectional big-data analysis in children from Oct 1, 2014, to Aug 1, 2018, using existing data derived from PAP devices uploaded nightly in the AirView cloud database. The AirView database is a usage tracking system available to all patients who are assigned PAP therapy, which requires consent from the patient or parent or guardian. All patients older than 4 years and younger than 18 years who used continuous or automated PAP devices were evaluated. Only patients living in the USA and enrolled with a single insurance company were included. If patients were participating in an engagement programme, programme onset must have been within 7 days of therapy onset. Our primary outcome was the proportion of patients who used PAP continuously over 90 days. The primary outcome was assessed in all patients who met the age inclusion criterion and had reliable age data available. Data on missing PAP use were imputed as zero, but data on other metrics were not imputed and excluded from analysis.
We used data recorded from Oct 1, 2014, to Aug 1, 2018. Of 40 140 children screened, 36 058 (89·8%) were US residents and 20 553 (90·1%) of them met the eligibility criteria and had accessible data (mean age 13·0 years [SD 3·7]). On the basis of 90 days of monitoring data, 12 699 (61·8%) patients continuously used PAP. Factors significantly associated with adherence included age group, residual apnoea-hypopnoea index, use and onset of patient engagement programmes, PAP pressure, and nightly median PAP mask leak, all over the 90-day study period.
To our knowledge, our study represents the largest analysis of children using PAP therapy to date. The findings suggest that adherence to PAP therapy is lower than in previous reports from adults. However, numerous actionable factors were associated with improvements in adherence and should be used strategically in clinical decision making to improve PAP adherence in children.
ResMed.
气道正压通气(PAP)已成为治疗儿童睡眠呼吸障碍的重要手段。但目前尚无大规模研究阐明儿童对 PAP 的耐受性如何,以及哪些因素与 PAP 治疗的依从性更好相关。本研究旨在阐明大量儿科人群中 PAP 治疗的依从模式。
我们对 2014 年 10 月 1 日至 2018 年 8 月 1 日期间使用 AirView 云数据库中每晚上传的 PAP 设备数据进行了一项基于大数据库的横断面分析。AirView 数据库是一个适用于所有接受 PAP 治疗的患者的使用情况跟踪系统,该系统需要患者或其父母或监护人同意。所有年龄大于 4 岁、小于 18 岁、使用持续或自动 PAP 设备的患者都进行了评估。仅纳入居住在美国、使用单一保险公司的患者。如果患者参与了一个参与项目,那么该项目的开始时间必须在治疗开始后的 7 天内。我们的主要结局是在 90 天内持续使用 PAP 的患者比例。主要结局评估了符合年龄纳入标准且有可靠年龄数据的所有患者。对 PAP 使用缺失数据进行了零假设填补,但对其他指标的数据未进行填补且未纳入分析。
我们使用了 2014 年 10 月 1 日至 2018 年 8 月 1 日期间的数据。在筛选的 40140 名儿童中,36058 名(89.8%)为美国居民,其中 20553 名(90.1%)符合入选标准且数据可获取(平均年龄 13.0 岁[标准差 3.7])。根据 90 天的监测数据,12699 名(61.8%)患者持续使用 PAP。在整个 90 天的研究期间,与依从性相关的显著因素包括年龄组、残余呼吸暂停低通气指数、患者参与项目的使用和开始时间、PAP 压力和夜间中位数 PAP 面罩泄漏。
据我们所知,本研究是迄今为止最大规模的使用 PAP 治疗的儿童分析。研究结果表明,与以往成人报告相比,儿童对 PAP 治疗的依从性较低。但是,许多可操作的因素与依从性的改善相关,在临床决策中应战略性地加以利用,以提高儿童对 PAP 的依从性。
ResMed。